Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil J Scolding

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Journal of the Neurological Sciences|August 3, 2007
Autologous bone marrow stem cells--properties and advantagesClaire M Rice, Neil J Scolding
Practical Neurology|October 26, 2019
The diagnosis of primary central nervous system vasculitisClaire M Rice, Neil J Scolding
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Adult stem cells for the treatment of neurological diseaseC M Rice, Neil J Scolding
Journal of Medical Case Reports|April 24, 2008
Accidental carbon monoxide poisoning presenting without a history of exposure: a case reportLuke Bennetto, Louise Powter, Neil J Scolding
CNS Drugs|April 12, 2017
Cell Therapy for Multiple SclerosisPamela Sarkar, Claire M Rice, Neil J Scolding
Neurology|August 19, 2007
CNS lupus: a study of 41 patientsFady G Joseph, G Alistair Lammie, Neil J Scolding
Neurology|March 20, 2019
Author response: Rare side effects of alemtuzumab remind us of the need for postmarketing surveillancePaolo A Muraro, Neil J Scolding, Robert J Fox
Journal of Neurology, Neurosurgery, and Psychiatry|November 4, 2008
Treatment of refractory neurosarcoidosis with InfliximabErnestina Santos, Sandip Shaunak, Shelley Renowden, et al.
Journal of Neuroimmunology|June 7, 2006
Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesionsHeather C Wilson, Neil J Scolding, Cedric S Raine
Neurology|April 1, 2018
Rare side effects of alemtuzumab remind us of the need for postmarketing surveillancePaolo A Muraro, Neil J Scolding, Robert J Fox
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Journal of the Neurological Sciences|August 3, 2007
Autologous bone marrow stem cells--properties and advantagesClaire M Rice, Neil J Scolding
Practical Neurology|October 26, 2019
The diagnosis of primary central nervous system vasculitisClaire M Rice, Neil J Scolding
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Adult stem cells for the treatment of neurological diseaseC M Rice, Neil J Scolding
Journal of Medical Case Reports|April 24, 2008
Accidental carbon monoxide poisoning presenting without a history of exposure: a case reportLuke Bennetto, Louise Powter, Neil J Scolding
CNS Drugs|April 12, 2017
Cell Therapy for Multiple SclerosisPamela Sarkar, Claire M Rice, Neil J Scolding
Neurology|August 19, 2007
CNS lupus: a study of 41 patientsFady G Joseph, G Alistair Lammie, Neil J Scolding
Neurology|March 20, 2019
Author response: Rare side effects of alemtuzumab remind us of the need for postmarketing surveillancePaolo A Muraro, Neil J Scolding, Robert J Fox
Journal of Neurology, Neurosurgery, and Psychiatry|November 4, 2008
Treatment of refractory neurosarcoidosis with InfliximabErnestina Santos, Sandip Shaunak, Shelley Renowden, et al.
Journal of Neuroimmunology|June 7, 2006
Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesionsHeather C Wilson, Neil J Scolding, Cedric S Raine
Neurology|April 1, 2018
Rare side effects of alemtuzumab remind us of the need for postmarketing surveillancePaolo A Muraro, Neil J Scolding, Robert J Fox
Pageof 6